{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:21Z","timestamp":1791229521560,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jpedsurg.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T02:06:36Z","timestamp":1526868396000},"page":"595-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report"],"prefix":"10.1016","volume":"54","author":[{"given":"Ghazi M.","family":"Al Edwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammam H.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Nabeeh M.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Shaath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawand","family":"Al Adwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Mahafza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameel M.","family":"Afram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ababneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Al Adwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muheilan M.","family":"Muheilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0010","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report for the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","article-title":"American Urological Association; Society of Urodynamics, female pelvic medicine. diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment","volume":"193","author":"Gormley","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of Antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.jpedsurg.2018.05.012_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0974-7796.82170","article-title":"Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder","volume":"3","author":"AlTaweel","year":"2011","journal-title":"Urol Ann"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/clinids\/1.4.701","volume":"1","author":"van Ermengem","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0040","first-page":"59","article-title":"Botulinum toxin a for the treatment of overactive bladder","volume":"8(3)","author":"Hsieh","year":"2016"},{"issue":"1","key":"10.1016\/j.jpedsurg.2018.05.012_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0970-1591.109975","article-title":"The use of botulinum toxin for the treatment of overactive bladder syndrome","volume":"29","author":"Orasanu","year":"2013","journal-title":"Indian J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0050","series-title":"Reliability of Arabic ICIQ-UI short form in Saudi Arabia","author":"Al-Shaikh","year":"2013"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2008.05.033","article-title":"Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder","author":"Colman","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0060","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.juro.2010.02.009","article-title":"Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature","volume":"183","author":"Anger","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin A in the overactive bladder: current status and future directions","volume":"99","author":"Dmochowski","year":"2007","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.jpedsurg.2018.05.012_bb0070","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"Onabotulinum toxin A 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomized double blind placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","article-title":"Efficacy and safety of low doses of onabotulinum toxin A for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study","volume":"61","author":"Denys","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/nau.21021","article-title":"Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinum toxin A in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder","volume":"30","author":"Rovner","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0090","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, doubleblind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0095","series-title":"Botulinum toxin injections in the management of non-neurogenic overactive bladders in children","author":"L\u00e9on","year":"2014"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1246193","article-title":"Effectiveness of botulinum a toxin for the treatment of refractory overactive bladder in children","volume":"20","author":"Marte","year":"2010","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0105","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpurol.2012.08.011","article-title":"Intravesical botulinum type A toxin (Dysport(r)) in the treatment of idiopathic detrusor overactivity in children","volume":"9","author":"Blackburn","year":"2013","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/00365599.2011.590997","article-title":"Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study","volume":"45","author":"Lahdes-Vasama","year":"2011","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum toxin type A in incontinent children with therapy resistant overactive detrusor","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0120","series-title":"Effect of onabotulinum toxin A treatment on symptoms and urodynamic findings in pediatric neurogenic bladder","author":"Kask","year":"2014"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0125","series-title":"Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder","author":"Khan","year":"2015"},{"issue":"12","key":"10.1016\/j.jpedsurg.2018.05.012_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005493.pub3","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0135","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","article-title":"Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinum toxin A) and dysport (abobotulinum toxin A)","volume":"60","author":"Mangera","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0140","series-title":"Guidelines Associates: M.S. Silay, S. Undre, J. Quaedackers, EAU Guidelines on pediatric urology","author":"Tekg\u00fcl (Chair)","year":"2017"},{"key":"10.1016\/j.jpedsurg.2018.05.012_bb0145","series-title":"Preoperative urodynamic factors predicting outcome of botulinum toxin-a intradetrusor injection in children with neurogenic detrusor overactivity","author":"Sang","year":"2014"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346818303385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346818303385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:33:38Z","timestamp":1758357218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346818303385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0022346818303385"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2018.05.012","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}